Cytek Biosciences
CTKB
CTKB
128 hedge funds and large institutions have $424M invested in Cytek Biosciences in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 56 increasing their positions, 40 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
22% less capital invested
Capital invested by funds: $541M → $424M (-$116M)
83% less call options, than puts
Call options by funds: $1K | Put options by funds: $6K
Holders
128
Holding in Top 10
–
Calls
$1K
Puts
$6K
Top Buyers
| 1 | +$5.52M | |
| 2 | +$4.76M | |
| 3 | +$4.69M | |
| 4 |
JP Morgan Chase
New York
|
+$3.14M |
| 5 |
Renaissance Technologies
New York
|
+$1.4M |
Top Sellers
| 1 | -$45.7M | |
| 2 | -$3.81M | |
| 3 | -$3.27M | |
| 4 |
BlackRock
New York
|
-$2.14M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.6M |